How much is Concert Pharmaceuticals worth in 2026?

Concert Pharmaceuticals has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Concert Pharmaceuticals raised?

Concert Pharmaceuticals has raised N/A in total funding across 1 funding rounds.

Concert Pharmaceuticals

Biotechnology

Concert Pharmaceuticals valuation and funding history | Last updated: November 5, 2021 | 1 funding rounds

Current Valuation

N/A

As of November 5, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$65.0M

Last Funding

Nov 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 5, 2021	PIPE	$65.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Concert Pharmaceuticals is currently valued at N/A as of November 5, 2021.

Track Concert Pharmaceuticals Valuation Updates

Get notified when Concert Pharmaceuticals raises new funding or valuation changes

Explore More Data

Detailed analysis for Concert Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Concert Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is Concert Pharmaceuticals Worth in 2026?

Concert Pharmaceuticals is a leading private company in the Biotechnology sector. Track Concert Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Concert Pharmaceuticals Valuation is Determined

Private company valuations like Concert Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.